157 related articles for article (PubMed ID: 1120392)
1. Disposition of methadone in methadone maintenance.
Anggård E; Gunne LM; Homstrand J; McMahon RE; Sandberg CG; Sullivan HR
Clin Pharmacol Ther; 1975 Mar; 17(3):258-66. PubMed ID: 1120392
[TBL] [Abstract][Full Text] [Related]
2. Effects of desipramine treatment on the biliary, fecal and urinary excretion of methadone in the rat.
Liu SJ; Chen KZ; Wang RI
J Pharmacol Exp Ther; 1976 Aug; 198(2):308-17. PubMed ID: 948028
[TBL] [Abstract][Full Text] [Related]
3. Effects of liver disease on fecal excretion of methadone and its unconjugated metabolites in maintenance patients. Quantitation by direct probe chemical ionization mass spectrometry.
Kreek MJ; Bencsath FA; Fanizza A; Field FH
Biomed Mass Spectrom; 1983 Oct; 10(10):544-9. PubMed ID: 6652228
[TBL] [Abstract][Full Text] [Related]
4. l-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites.
Billings RE; McMahon RE; Blake DA
Life Sci; 1974 Apr; 14(8):1437-46. PubMed ID: 4829538
[No Abstract] [Full Text] [Related]
5. Excretion of methadone and metabolites in human sweat.
Henderson GL; Wilson BK
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):1-8. PubMed ID: 4686102
[No Abstract] [Full Text] [Related]
6. Urinary metabolites of dl-methadone in maintenance subjects.
Sullivan HR; Due SL
J Med Chem; 1973 Aug; 16(8):909-13. PubMed ID: 4745834
[No Abstract] [Full Text] [Related]
7. Methadone-disulfiram interaction during methadone maintenance.
Tong TG; Benowitz NL; Kreek MJ
J Clin Pharmacol; 1980; 20(8-9):506-13. PubMed ID: 7430415
[TBL] [Abstract][Full Text] [Related]
8. CSF-endorphins in heroin addicts during methadone maintenance and during withdrawal.
Holmstrand J; Gunne LM; Wahlström A; Terenius L
Pharmacopsychiatria; 1981 Jul; 14(4):126-8. PubMed ID: 7280011
[TBL] [Abstract][Full Text] [Related]
9. Biliary secretion of methadone and methadone metabolites in man.
Kreek MJ; Kalisman M; Irwin M; Jaffery NF; Scheflan M
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):67-78. PubMed ID: 7403680
[TBL] [Abstract][Full Text] [Related]
10. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
Wu WN; Masucci JA; Caldwell GW; Carson JR
Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions with methadone.
Kreek MJ; Gutjahr CL; Garfield JW; Bowen DV; Field FH
Ann N Y Acad Sci; 1976; 281():350-71. PubMed ID: 798526
[No Abstract] [Full Text] [Related]
12. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
13. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
Prakash C; O'Donnell J; Khojasteh-Bakht SC
Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
[TBL] [Abstract][Full Text] [Related]
14. Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: quantitation by direct probe chemical ionization mass spectrometry.
Kreek MJ; Bencsath FA; Field FH
Biomed Mass Spectrom; 1980 Sep; 7(9):385-95. PubMed ID: 7470591
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state.
Anggård E; Nilsson MI; Holmstrand J; Gunne LM
Eur J Clin Pharmacol; 1979 Aug; 16(1):53-7. PubMed ID: 499301
[TBL] [Abstract][Full Text] [Related]
16. Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
Kassahun K; Mattiuz E; Nyhart E; Obermeyer B; Gillespie T; Murphy A; Goodwin RM; Tupper D; Callaghan JT; Lemberger L
Drug Metab Dispos; 1997 Jan; 25(1):81-93. PubMed ID: 9010634
[TBL] [Abstract][Full Text] [Related]
17. Physiological disposition and metabolism of timolol in man and laboratory animals.
Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.
Caldwell GW; Wu WN; Masucci JA
Xenobiotica; 2001 Nov; 31(11):823-39. PubMed ID: 11765144
[TBL] [Abstract][Full Text] [Related]
19. Methadone plasma level: sustained by a reservoir of drug in tissue.
Dole VP; Kreek MJ
Proc Natl Acad Sci U S A; 1973 Jan; 70(1):10. PubMed ID: 4509643
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and probable active metabolite of alpha-l-acetylmethadol in rat.
Kochhar MM; Davidson PP; Bhushan RS
Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):251-63. PubMed ID: 847284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
